PM
RNTX

Prosight Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Prosight Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$599K Sell
427,919
-2,081
-0.5% -$2.91K 0.15% 36
2025
Q1 		$761K Buy
430,000
+25,021
+6% +$44.3K 0.25% 35
2024
Q4 		$931K Buy
404,979
+32,822
+9% +$75.5K 0.26% 33
2024
Q3 		$1.32M Buy
372,157
+107,157
+40% +$379K 0.32% 36
2024
Q2 		$734K Buy
+265,000
New +$734K 0.22% 43